🌎 Microsoft Downgraded, Affirm Upgraded, QUALCOMM Downgraded and more…

RJ Hamster

2 months ago

Ratings changes for Microsoft, Cassava Sciences, JD.com, Affirm, QUALCOMM, SolarEdge Technologies, Micron Technology and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.

Unsubscribe.

VIEW MY PORTFOLIO

OCTOBER 8TH, 2024

320 hedge funds just sold this stock (ad)

320 hedge funds just sold this stock

A strange force has seized control of Wall Street. Hedge funds are already moving their money… and preparing for even stranger days ahead. Over 320 hedge funds have quietly sold THIS famous stock – to prepare for a dramatic market shift

GET THE STRANGE TRUTH FROM A 50-YEAR WALL STREET INSIDER… INCLUDING THE NAME AND TICKER OF THE STOCK

Today’s Top Stories

These Stocks Are Using Buybacks to Unlock Big Gains for Investors

BY GABRIEL OSORIO-MAZILLI | OCTOBER 8, 2024 09:42 AM

Last chance to watch (Ad)

BY PORTER & COMPANY

States sue TikTok, claiming its platform is addictive and harms the mental health of children

BY THE ASSOCIATED PRESS | OCTOBER 8, 2024 09:08 AM

This Is the Entry Into PepsiCo You’ve Been Waiting For

BY THOMAS HUGHES | OCTOBER 8, 2024 08:55 AM

Prepare for a Recession Unlike Any Other (Ad)

BY AMERICAN HARTFORD GOLD GROUP

PepsiCo lowers revenue forecast on “subdued” sales in US, China and elsewhere

BY THE ASSOCIATED PRESS | OCTOBER 8, 2024 05:09 AM

3 Dividend-Paying Chip Stocks You Don’t Want to Miss

BY LEO MILLER | OCTOBER 8, 2024 08:31 AM

Quick Links

MarketBeat All Access

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (ad)

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs…

A predicted Trump would win.

You won’t believe what he’s predicting now.

CLICK HERE TO SEE IT BECAUSE IT’S A SHOCKER…

Your Watchlist

MANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIO

Apple Inc. (AAPL)

(10/8) Think You Missed the AI Boom? These 3 Stocks Are Just Starting (AAPL)(marketbeat.com)
(10/8) Top Stock Movers Now: Humana, Amazon, Apple, and More (msn.com)
(10/8) Apple’s stock draws a downgrade as AI optimism may be very premature(morningstar.com)
(10/8) Warren Buffett Sold Half of Apple (AAPL) Shares in Q3 (msn.com)
(10/8) Apple Stock Forecast: Is AAPL a Good Buy Near All-Time Highs? (msn.com)

Amazon.com, Inc. (AMZN)

Alphabet Inc. (GOOGL)

(10/8) Google (GOOGL) Faces Major Overhaul Due to Antitrust Ruling (gurufocus.com)
(10/8) US to propose how Google should boost online search competition (reuters.com)
(10/8) What comes next in Google’s antitrust case over search? (reuters.com)
(10/8) Google must allow third-party app stores on Android, Epic Games judge rules(businessinsider.com)
(10/8) Federal judge orders Google to open its Android app store to competition(techxplore.com)

Meta Platforms, Inc. (META)

Microsoft Co. (MSFT)

Microsoft (NASDAQ:MSFT) was downgraded by analysts at Oppenheimer Holdings Inc. ( ) from an “outperform” rating to a “market perform” rating.The current price is $413.35.
(10/8) IriusRisk partners with Adam Shostack to deliver threat modeling coaching services(financialpost.com)
(10/8) CrashPlan Acquires Microsoft Partner Parablu to Extend M365 Protection(globenewswire.com)
(10/8) Better Quantum Computing Stock: Microsoft vs. IonQ (fool.com)
(10/8) Best Buy: AI Demand Is Recharging the Electronics Upgrade Cycle (MSFT)(marketbeat.com)
(10/8) Top 3 Growth Stocks Poised for a Strong Q4 2024 Rally (MSFT) (marketbeat.com)

MANAGE YOUR WATCHLIST

Analysts’ Upgrades

Affirm (NASDAQ:AFRM) was upgraded by analysts at BTIG Research from a “neutral” rating to a “buy” rating. They now have a $68.00 price target on the stock. This represents a 68.5% upside from the current price of $40.36.

CEMEX (NYSE:CX) was upgraded by analysts at Royal Bank of Canada from an “underperform” rating to a “sector perform” rating. They now have a $6.50 price target on the stock, down previously from $9.00. This represents a 11.3% upside from the current price of $5.84.

Humana (NYSE:HUM) was upgraded by analysts at Sanford C. Bernstein from a “market perform” rating to an “outperform” rating. They now have a $308.00 price target on the stock. This represents a 26.5% upside from the current price of $243.43.

McDonald’s (NYSE:MCD) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating.The current price is $301.08.

Cassava Sciences (NASDAQ:SAVA) was upgraded by analysts at HC Wainwright from a “neutral” rating to a “buy” rating. They now have a $116.00 price target on the stock. This represents a 291.4% upside from the current price of $29.64.

Sun Country Airlines (NASDAQ:SNCY) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating. They now have a $14.00 price target on the stock. This represents a 30.1% upside from the current price of $10.76.

Ubisoft Entertainment (OTCMKTS:UBSFY) was upgraded by analysts at UBS Group AG from a “sell” rating to a “neutral” rating.The current price is $2.95.

UFP Industries (NASDAQ:UFPI) was upgraded by analysts at Wedbush from a “neutral” rating to an “outperform” rating. They now have a $155.00 price target on the stock, up previously from $120.00. This represents a 16.6% upside from the current price of $132.94.

UWM (NYSE:UWMC) was upgraded by analysts at Barclays PLC from an “underweight” rating to an “equal weight” rating. They now have a $8.00 price target on the stock, up previously from $6.00. This represents a 9.0% upside from the current price of $7.34.

Waters (NYSE:WAT) was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $415.00 price target on the stock, up previously from $355.00. This represents a 16.0% upside from the current price of $357.66.

Wells Fargo & Company (NYSE:WFC) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating. They now have a $65.00 price target on the stock. This represents a 13.0% upside from the current price of $57.54.

VIEW MORE UPGRADES

10 Best EV Stocks to Invest in Today (ad)

EV stocks are red hot.

We’ve found TEN that we think will produce big wins for early investors.

There’s no charge to view this report, so I urge everyone to check out the 10 stocks we’ve found as soon as possible.

CLICK HERE TO VIEW ALL 10 STOCKS RIGHT AWAY.

Analysts’ Downgrades

American Express (NYSE:AXP) was downgraded by analysts at BTIG Research from a “neutral” rating to a “sell” rating. They now have a $230.00 price target on the stock. This represents a 14.7% downside from the current price of $269.50.

American Express (NYSE:AXP) was downgraded by analysts at HSBC Holdings plc from a “buy” rating to a “hold” rating. They now have a $270.00 price target on the stock, up previously from $265.00. This represents a 0.2% upside from the current price of $269.50.

Anheuser-Busch InBev SA/NV (NYSE:BUD) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $88.00 price target on the stock, up previously from $68.00. This represents a 37.1% upside from the current price of $64.21.

CME Group (NASDAQ:CME) was downgraded by analysts at Redburn Atlantic from a “buy” rating to a “neutral” rating. They now have a $244.00 price target on the stock. This represents a 9.7% upside from the current price of $222.41.

Frontier Communications Parent (NASDAQ:FYBR) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $38.50 price target on the stock, down previously from $39.00. This represents a 8.8% upside from the current price of $35.39.

Microsoft (NASDAQ:MSFT) was downgraded by analysts at Oppenheimer Holdings Inc. from an “outperform” rating to a “market perform” rating.The current price is $412.97.

OneMain (NYSE:OMF) was downgraded by analysts at Barclays PLC from an “overweight” rating to an “equal weight” rating. They now have a $46.00 price target on the stock, down previously from $52.00. This represents a 0.3% upside from the current price of $45.88.

Otis Worldwide (NYSE:OTIS) was downgraded by analysts at Wolfe Research from an “outperform” rating to a “peer perform” rating.The current price is $101.09.

QUALCOMM (NASDAQ:QCOM) was downgraded by analysts at KeyCorp from an “overweight” rating to a “sector weight” rating.The current price is $166.04.

Constellation Brands (NYSE:STZ) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $270.00 price target on the stock, down previously from $300.00. This represents a 13.1% upside from the current price of $238.80.

Synaptics (NASDAQ:SYNA) was downgraded by analysts at KeyCorp from an “overweight” rating to a “sector weight” rating.The current price is $74.00.

Trip.com Group (NASDAQ:TCOM) was downgraded by analysts at HSBC Holdings plc from a “buy” rating to a “hold” rating.The current price is $62.97.

VIEW MORE DOWNGRADES

Don’t Miss Out! Get 2 Hot AI Stocks for Under $10/Share 🚀 (ad)

Artificial Intelligence (AI) stocks are booming, and now is your chance to get in on the action — without breaking the bank!

We’ve just uncovered 2 must-buy AI stocks trading for under $10/share, and they’re showing serious potential for growth.

CLICK HERE TO GET YOUR FREE REPORT DELIVERED INSTANTLY!

Analysts’ New Coverage

Abbott Laboratories (NYSE:ABT) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $130.00 price target on the stock. This represents a 13.9% upside from the current price of $114.18.

Arcellx (NASDAQ:ACLX) is now covered by analysts at Redburn Atlantic. They set a “buy” rating and a $109.00 price target on the stock. This represents a 40.6% upside from the current price of $77.50.

Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating on the stock.The current price is $23.21.

Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $47.00 price target on the stock. This represents a 102.5% upside from the current price of $23.21.

Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at TD Cowen. They set a “buy” rating on the stock.The current price is $23.21.

Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $35.00 price target on the stock. This represents a 50.8% upside from the current price of $23.21.

Barclays (NYSE:BCS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating on the stock.The current price is $12.06.

Bitdeer Technologies Group (NASDAQ:BTDR) is now covered by analysts at Alliance Global Partners. They set a “buy” rating and a $14.00 price target on the stock. This represents a 96.1% upside from the current price of $7.14.

CION Investment (NYSE:CION) is now covered by analysts at Oppenheimer Holdings Inc.. They set a “market perform” rating and a $13.00 price target on the stock. This represents a 10.4% upside from the current price of $11.78.

CrowdStrike (NASDAQ:CRWD) is now covered by analysts at BNP Paribas. They set a “neutral” rating and a $285.00 price target on the stock. This represents a 1.3% downside from the current price of $288.89.

Curbline Properties (NYSE:CURB) is now covered by analysts at Citigroup Inc.. They set a “neutral” rating and a $25.00 price target on the stock. This represents a 5.6% upside from the current price of $23.68.

Datadog (NASDAQ:DDOG) is now covered by analysts at BNP Paribas. They set an “outperform” rating and a $150.00 price target on the stock. This represents a 20.2% upside from the current price of $124.79.

Dynatrace (NYSE:DT) is now covered by analysts at BNP Paribas. They set a “neutral” rating and a $52.00 price target on the stock. This represents a 2.5% downside from the current price of $53.33.

First National (NASDAQ:FXNC) is now covered by analysts at Hovde Group. They set an “outperform” rating and a $22.00 price target on the stock. This represents a 18.3% upside from the current price of $18.59.

Genmab A/S (NASDAQ:GMAB) is now covered by analysts at Redburn Atlantic. They set a “buy” rating on the stock.The current price is $23.59.

GRI Bio (NASDAQ:GRI) is now covered by analysts at Ascendiant Capital Markets. They set a “buy” rating and a $12.00 price target on the stock.

Howmet Aerospace (NYSE:HWM) is now covered by analysts at Susquehanna. They set a “positive” rating and a $120.00 price target on the stock. This represents a 16.1% upside from the current price of $103.35.

Samsara (NYSE:IOT) is now covered by analysts at BNP Paribas. They set a “neutral” rating and a $46.00 price target on the stock. This represents a 3.5% downside from the current price of $47.65.

Legend Biotech (NASDAQ:LEGN) is now covered by analysts at Redburn Atlantic. They set a “buy” rating and a $86.00 price target on the stock. This represents a 76.8% upside from the current price of $48.65.

Light & Wonder (NASDAQ:LNW) is now covered by analysts at B. Riley. They set a “buy” rating and a $120.00 price target on the stock. This represents a 24.9% upside from the current price of $96.08.

MBX Biosciences (NYSE:MBX) is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $30.00 price target on the stock. This represents a 29.3% upside from the current price of $23.20.

MBX Biosciences (NYSE:MBX) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $35.00 price target on the stock. This represents a 50.9% upside from the current price of $23.20.

MBX Biosciences (NYSE:MBX) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $40.00 price target on the stock. This represents a 72.4% upside from the current price of $23.20.

MBX Biosciences (NYSE:MBX) is now covered by analysts at Guggenheim. They set a “buy” rating and a $44.00 price target on the stock. This represents a 89.7% upside from the current price of $23.20.

Morningstar (NASDAQ:MORN) is now covered by analysts at UBS Group AG. They set a “buy” rating and a $390.00 price target on the stock. This represents a 19.5% upside from the current price of $326.42.

Cloudflare (NYSE:NET) is now covered by analysts at BNP Paribas. They set an “underperform” rating and a $65.00 price target on the stock. This represents a 19.8% downside from the current price of $81.00.

Envista (NYSE:NVST) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $20.00 price target on the stock. This represents a 8.3% upside from the current price of $18.47.

Arcus Biosciences (NYSE:RCUS) is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $29.00 price target on the stock. This represents a 55.7% upside from the current price of $18.63.

Sable Offshore (NYSE:SOC) is now covered by analysts at BWS Financial. They set a “sell” rating and a $6.00 price target on the stock. This represents a 71.9% downside from the current price of $21.36.

Solventum (NYSE:SOLV) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $82.00 price target on the stock. This represents a 20.1% upside from the current price of $68.29.

Veeva Systems (NYSE:VEEV) is now covered by analysts at BNP Paribas. They set an “outperform” rating and a $286.00 price target on the stock. This represents a 39.7% upside from the current price of $204.74.

Zapp Electric Vehicles Group (NASDAQ:ZAPP) is now covered by analysts at Maxim Group. They set a “buy” rating and a $7.00 price target on the stock. This represents a 161.2% upside from the current price of $2.68.

ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at Citigroup Inc.. They set a “buy” rating and a $27.00 price target on the stock. This represents a 44.4% upside from the current price of $18.70.

ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $35.00 price target on the stock. This represents a 87.2% upside from the current price of $18.70.

ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $40.00 price target on the stock. This represents a 113.9% upside from the current price of $18.70.

ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at Guggenheim. They set a “buy” rating and a $45.00 price target on the stock. This represents a 140.6% upside from the current price of $18.70.

Zscaler (NASDAQ:ZS) is now covered by analysts at BNP Paribas. They set a “neutral” rating and a $180.00 price target on the stock. This represents a 2.6% upside from the current price of $175.52.

VIEW MORE NEW COVERAGE

Calendars from MarketBeat

U.S. Analyst Ratings

Corporate Buybacks

Cryptocurrencies

Dividend Declarations

Earnings Announcements

Earnings Conference Calls

Economic Reports

Gap Up/Down Stocks

Insider Trades

Initial Public Offerings (IPOs)

Most Active Stocks

Percentage Gainers/Decliners

Sector Performance

Short Interest

Stock Splits

Unusual Options Volume

Unusual Trading Volume

GET 30 DAYS OF MARKETBEAT ALL ACCESS FREE

Best-in-Class Portfolio Monitoring

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools

Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.